Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease

Journal of Molecular and Cellular Cardiology

Volumn 61, Issue , 2013, Pages 111-122

  Toischer, Karl ^a   Hartmann, Nico ^a   Wagner, Stefan ^a   Fischer, Thomas H ^a   Herting, Jonas ^a   Danner, Bernhard C ^a   Sag, Can M ^a   Hund, Thomas J ^b   Mohler, Peter J ^b   Belardinelli, Luiz ^c   Hasenfuss, Gerd ^a   Maier, Lars S ^a   Sossalla, Samuel ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c Gilead Sciences   (United States)

Author keywords

Arrhythmias; CaMKII; Heart failure; Hypertrophy; INaL; Ranolazine

Indexed keywords

SODIUM CHANNEL; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.5;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ARRHYTHMIAS; CAMKII; HEART FAILURE; HYPERTROPHY; I(NAL); RANOLAZINE;

ACETANILIDES; ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMEGALY; CELLS, CULTURED; FEMALE; HEART FAILURE; HEART VENTRICLES; MICE; MICE, INBRED C57BL; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; PATCH-CLAMP TECHNIQUES; PEPTIDES; PIPERAZINES; SODIUM; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN;

ANIMALIA; MUS;

EID: 84880328248     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.03.021     Document Type: Article

References (41)

1. Bers D.M. Excitation-contraction coupling and cardiac contractile force 2001, Kluwer Academic Publishers, Dordrecht, Netherlands. 2nd ed.
2. + channels. J Clin Invest 2006, 116:3127-3138.
3. 2+ accumulation in chronic heart failure. J Physiol Sci 2010, 60:245-257.
4. Undrovinas A.I., Maltsev V.A., Sabbah H.N. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 1999, 55:494-505.
5. + current. Basic Res Cardiol 2011, 106:263-272.
6. Song Y., Shryock J.C., Wagner S., Maier L.S., Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006, 318:214-222.
7. Song Y., Shryock J.C., Belardinelli L. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am J Physiol Heart Circ Physiol 2008, 294:H2031-H2039.
8. Maltsev V.A., Undrovinas A. Late sodium current in failing heart: friend or foe?. Prog Biophys Mol Biol 2008, 96:421-451.
9. Maltsev V.A., Sabbah H.N., Higgins R.S., Silverman N., Lesch M., Undrovinas A.I. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998, 98:2545-2552.
10. Belardinelli L., Shryock J.C., Fraser H. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 2006, 92(Suppl. 4):iv6-iv14.
11. + pump function is unchanged. Circulation 2002, 105:2543-2548.
12. Valdivia C.R., Chu W.W., Pu J., Foell J.D., Haworth R.A., Wolff M.R., et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005, 38:475-483.
13. Ju Y.K., Saint D.A., Gage P.W. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 1996, 497:337-347.
14. Sossalla S., Maier L.S. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes. Pharmacol Ther 2012, 133:311-322.
15. Maltsev V.A., Silverman N., Sabbah H.N., Undrovinas A.I. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 2007, 9:219-227.
16. 2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010, 107:1150-1161.
17. Lederer W.J., Tsien R.W. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol 1976, 263:73-100.
18. Sossalla S., Wagner S., Rasenack E.C., Ruff H., Weber S.L., Schondube F.A., et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J Mol Cellular Cardiol. 2008, 45:32-43.
19. + currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 2010, 55:2330-2342.
20. Mishra S., Undrovinas N.A., Maltsev V.A., Reznikov V., Sabbah H.N., Undrovinas A. Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure. Am J Physiol Heart Circ Physiol 2011, 301:H1596-H1605.
21. Hund T.J., Koval O.M., Li J., Wright P.J., Qian L., Snyder J.S., et al. A beta(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 2010, 120:3508-3519.
22. 2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. J Biol Chem 2012, 287:19856-19869.
23. Boulaksil M., Winckels S.K., Engelen M.A., Stein M., van Veen T.A., Jansen J.A., et al. Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail 2010, 12:913-921.
24. Toischer K., Rokita A.G., Unsold B., Zhu W., Kararigas G., Sossalla S., et al. Differential cardiac remodeling in preload versus afterload. Circulation 2010, 122:993-1003.
25. Antzelevitch C., Belardinelli L., Zygmunt A.C., Burashnikov A., Di Diego J.M., Fish J.M., et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004, 110:904-910.
26. Maltsev V.A., Undrovinas A.I. Relationship between steady-state activation and availability of cardiac sodium channel: evidence of uncoupling. Cell Mol Life Sci 1998, 54:148-151.
27. Undrovinas A.I., Belardinelli L., Undrovinas N.A., Sabbah H.N. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 2006, 17(Suppl. 1):S169-S177.
28. Xi Y., Wu G., Yang L., Han K., Du Y., Wang T., et al. Increased late sodium currents are related to transcription of neuronal isoforms in a pressure-overload model. Eur J Heart Fail 2009, 11:749-757.
29. Wu L., Shryock J.C., Song Y., Belardinelli L. An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 2006, 316:718-726.
30. Wu L., Rajamani S., Shryock J.C., Li H., Ruskin J., Antzelevitch C., et al. Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. Cardiovasc Res 2008, 77:481-488.
31. 2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes. Cardiovasc Res 2010, 85:454-463.
32. + influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol 2011, 301:C577-C586.
33. Klensch H. The basal noradrenaline level in human peripheral venous blood. Pflugers Arch Gesamte Physiol Menschen Tiere 1966, 290:218-224.
34. i and contractility in nonfailing and failing human myocardium. Circulation 2002, 106:447-453.
35. Mallwitz A., Sag C.M., Sossalla S.T., Hartmann N., Steuer N., Sowa T., et al. CaMKII-dependent SR Ca leak contributes to proarrhythmogenic effects of increased late Na current in isolated cardiac myocytes. Clin Res Cardiol 2011, (Suppl. 1).
36. + channel in cardiac disease. Circulation 2012, 126:2084-2094.
37. Ma J., Luo A., Wu L., Wan W., Zhang P., Ren Z., et al. Calmodulin kinase II and protein kinase C mediate the effect of increased intracellular calcium to augment late sodium current in rabbit ventricular myocytes. Am J Physiol Cell Physiol 2011, 15:C1141-C1151.
38. Parikh A., Mantravadi R., Kozhevnikov D., Roche M.A., Ye Y., Owen L.J., et al. Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Heart Rhythm 2012, 9:953-960.
39. Wasserstrom J.A., Sharma R., O'Toole M.J., Zheng J., Kelly J.E., Shryock J., et al. Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart. J Pharmacol Exp Ther 2009, 331:382-391.
40. Song Y., Shryock J.C., Wu L., Belardinelli L. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 2004, 44:192-199.
41. Maier L.S., Layug B., Karwatowska-Prokopczuk E., Belardinelli L., Lee S., Sander J., et al. RAnoLazIne for the treatment of Diastolic Heart Failure in patients with preserved ejection fraction: The RALI-DHF proof-of-concept study. JACC: Heart Failure 2013, 1:115-122.